Amgen AMGN Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amgen's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amgen's other intangible assets—net?
- Amgen (AMGN) reported other intangible assets—net of $21.38B in Q1 2026.
- How has Amgen's other intangible assets—net changed year-over-year?
- Amgen's other intangible assets—net decreased by 16.9% year-over-year, from $25.72B to $21.38B.
- What is the long-term trend for Amgen's other intangible assets—net?
- Over 5 years (2020 to 2025), Amgen's other intangible assets—net has grown at a 6.1% compound annual growth rate (CAGR), from $16.59B to $22.28B.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.